ConductScience.org, home

Paper9723819

Population pharmacokinetics of ondansetron: a covariate analysis.

de Alwis DP and 2 others. Br J Clin Pharmacol, 1998. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Population pharmacokinetics of ondansetron: a covariate analysis. Papers, record 9723819. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9723819

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Population pharmacokinetics of ondansetron: a covariate analysis.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1998
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.62
iCite
Revised in PubMed
2026-09-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1de Alwis DPD P
2Aarons LL
3Palmer JLJ L

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntiemeticsMajor topic
OndansetronMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Analysis of Variance
Child
Child, Preschool
Demography
Female
Humans
Male
Metabolic Clearance Rate
Middle Aged
Models, Statistical

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12348382Evaluation of population (NONMEM) pharmacokinetic parameter estimates.J Pharmacokinet Biopharm1990https://conductscience.org/library/papers/2348382PubMed
28690814Pharmacokinetics of ondansetron in patients with hepatic insufficiency.J Clin Pharmacol1996https://conductscience.org/library/papers/8690814PubMed
31531044Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers.Clin Pharmacol Ther1992https://conductscience.org/library/papers/1531044PubMed
41839313Determination of ondansetron in plasma and its pharmacokinetics in the young and elderly.J Pharm Sci1991https://conductscience.org/library/papers/1839313PubMed
51559308Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling.Clin Pharmacokinet1992https://conductscience.org/library/papers/1559308PubMed
61587058Pharmacokinetics of quinidine in male patients. A population analysis.Clin Pharmacokinet1992https://conductscience.org/library/papers/1587058PubMed
71387254Ondansetron metabolism and pharmacokinetics.Semin Oncol1992https://conductscience.org/library/papers/1387254PubMed
81287200Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effects.J Pharmacokinet Biopharm1992https://conductscience.org/library/papers/1287200PubMed
97691500Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.Drugs1993https://conductscience.org/library/papers/7691500PubMed
108013282The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.Drug Metab Dispos1994https://conductscience.org/library/papers/8013282PubMed
118018461The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine.Br J Clin Pharmacol1994https://conductscience.org/library/papers/8018461PubMed
127929872Oral ondansetron pharmacokinetics: the effect of chemotherapy.J Clin Pharmacol1994https://conductscience.org/library/papers/7929872PubMed
137554705Pharmacokinetics of intravenous ondansetron in healthy children undergoing ear, nose, and throat surgery.Clin Pharmacol Ther1995https://conductscience.org/library/papers/7554705PubMed
148591723Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.Drug Metab Dispos1995https://conductscience.org/library/papers/8591723PubMed
158786955Population pharmacokinetic modeling: the importance of informative graphics.Pharm Res1995https://conductscience.org/library/papers/8786955PubMed
161920085A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam.J Pharmacokinet Biopharm1991https://conductscience.org/library/papers/1920085PubMed

Download CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
32495990Plasma and cerebrospinal fluid pharmacokinetics of ondansetron in humans.Br J Clin Pharmacol2021https://conductscience.org/library/papers/32495990PubMed
30976908Population pharmacokinetics of palonosetron and model-based assessment of dosing strategies.J Anesth2019https://conductscience.org/library/papers/30976908PubMed
27195435Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients.Br J Clin Pharmacol2016https://conductscience.org/library/papers/27195435PubMed
26558626Population pharmacokinetics of ramosetron.J Pharmacokinet Pharmacodyn2016https://conductscience.org/library/papers/26558626PubMed
19798490Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months.Eur J Clin Pharmacol2010https://conductscience.org/library/papers/19798490PubMed
17324241Population pharmacokinetics of melphalan in paediatric blood or marrow transplant recipients.Br J Clin Pharmacol2007https://conductscience.org/library/papers/17324241PubMed
16675509Ondansetron does not reduce the shivering threshold in healthy volunteers.Br J Anaesth2006https://conductscience.org/library/papers/16675509PubMed
15025739Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.Br J Clin Pharmacol2004https://conductscience.org/library/papers/15025739PubMed
14678339Population pharmacokinetics of weekly docetaxel in patients with advanced cancer.Br J Clin Pharmacol2004https://conductscience.org/library/papers/14678339PubMed
12889740Clinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug development: the capecitabine experience.Invest New Drugs2003https://conductscience.org/library/papers/12889740PubMed
12194534Population pharmacokinetic analysis of the major metabolites of capecitabine.J Pharmacokinet Pharmacodyn2002https://conductscience.org/library/papers/12194534PubMed
11736878Population pharmacokinetics of amphotericin B in children with malignant diseases.Br J Clin Pharmacol2001https://conductscience.org/library/papers/11736878PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9723819

GET https://conductscience.org/api/papers/v1/9723819/authors